Medical devices, healthcare technology and the business of care
510(k) clearance · K253836

FCT iStream Phase 2

Fujifilm Corporation · Decision date Sep 4, 2026

MEDTECHLEDGER EXPLANATIONK253836

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for K253836, FCT iStream Phase 2, on 2026-09-04. The submission was received 12/01/2025 and listed under device classification name System, X-Ray, Tomography, Computed, regulation number 892.1750, product code JAK, with radiology as the regulation medical specialty and review panel. The applicant is Fujifilm Corporation; the correspondent is FUJIFILM Healthcare Americas Corporation. The record describes a traditional 510(k), not reviewed by a third party, not a combination product, and without an authorized predetermined change control plan.

SESE means FDA found the submission substantially equivalent to a legally marketed predicate device, which is a clearance rather than premarket approval. The record does not identify the predicate device, the specific components or changes distinguishing Phase 2 from earlier versions, or the contents of any summary; those details would need the underlying submission documents. No clinical, efficacy or labeling conclusions are drawn here.

The page lists a last-updated date of 10/26/2026, later than the decision date, and the source provides no statement text.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Sep 4, 2026
FDA decision documents: 510(k) Premarket Notification - FDA

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K253836
Regulatory pathway
510(k) premarket notification
Product code
JAK
Decision code
SESE
Decision date
Sep 4, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, X-Ray, Tomography, Computed.

Product code
JAK
FDA device class
2

FDA decision timeline

  1. K253836 received

    Application receipt date recorded by FDA.

  2. K253836 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code JAK

Product / regulatory recordCompanyPathwayDecision dateSource
Coreline Soft Co., Ltd.510(k) clearanceOct 16, 2026FDA
CAS-One IRK261225
Cascination AG510(k) clearanceSep 29, 2026FDA
Samsung HME America, Inc., dba NeuroLogica Corp.510(k) clearanceSep 22, 2026FDA
Fujifilm Corporation510(k) clearanceSep 18, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Fujifilm Corporation

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Minato-Ku

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records